If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
8th Oct 20213:49 pmRNSNet Asset Value(s)
6th Oct 20219:38 amRNSTransaction in Own Shares
4th Oct 20216:06 pmRNSHalf-year Report
1st Oct 20216:23 pmRNSNet Asset Value(s)
1st Oct 20218:34 amRNSTotal Voting Rights
27th Sep 20218:57 amRNSNet Asset Value(s)
20th Sep 20218:53 amRNSNet Asset Value(s)
15th Sep 20218:48 amRNSTransaction in Own Shares
13th Sep 20218:46 amRNSTransaction in Own Shares
10th Sep 20213:51 pmRNSNet Asset Value(s)
2nd Sep 20218:54 amRNSNet Asset Value(s)
2nd Sep 20218:27 amRNSTotal Voting Rights
31st Aug 202112:03 pmRNSNet Asset Value(s)
25th Aug 20219:53 amRNSIssue of Equity
23rd Aug 20218:46 amRNSNet Asset Value(s)
16th Aug 20218:44 amRNSNet Asset Value(s)
13th Aug 20211:13 pmRNSTransaction in Own Shares
13th Aug 20219:01 amRNSDirector/PDMR Shareholding
11th Aug 20216:24 pmRNSDirector/PDMR Shareholding
10th Aug 202112:14 pmRNSIssue of Equity
9th Aug 20218:36 amRNSNet Asset Value(s)
4th Aug 20213:30 pmRNSOffer for Subscription - Update
3rd Aug 202112:03 pmRNSNet Asset Value(s)
2nd Aug 20218:56 amRNSTotal Voting Rights
28th Jul 20215:14 pmRNSOffer for subscription and Issue of Prospectus
26th Jul 202110:21 amRNSDirector/PDMR Shareholding
26th Jul 202110:17 amRNSIssue of Equity - DRIS
26th Jul 20218:23 amRNSNet Asset Value(s)
19th Jul 20211:48 pmRNSTransaction in Own Shares
19th Jul 202111:42 amRNSNet Asset Value(s)
16th Jul 202112:25 pmRNSTransaction in Own Shares
12th Jul 20218:38 amRNSNet Asset Value(s)
2nd Jul 202110:35 amRNSNet Asset Value(s)
1st Jul 20218:56 amRNSTotal Voting Rights
25th Jun 20215:37 pmRNSNet Asset Value(s)
22nd Jun 20215:22 pmRNSUpdate on Offer for Subscription
22nd Jun 20219:10 amRNSTransaction in Own Shares
21st Jun 202111:54 amRNSTransaction in Own Shares
18th Jun 20215:27 pmRNSNet Asset Value(s)
14th Jun 202110:02 amRNSNet Asset Value(s)
14th Jun 20219:43 amRNSTransaction in Own Shares
10th Jun 20217:00 amRNSDirectorate Change
10th Jun 20217:00 amRNSResult of AGM
7th Jun 20218:42 amRNSNet Asset Value(s)
2nd Jun 20219:09 amRNSNet Asset Value(s)
1st Jun 20211:11 pmRNSTotal Voting Rights
27th May 20211:15 pmRNSDirectorate Change
21st May 20215:35 pmRNSNet Asset Value(s)
17th May 20219:03 amRNSNet Asset Value(s)
12th May 202111:56 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.